30 varieties to fight the price war! National minimum prices at least 30% lower

Pharmaceutical Network August 5, August 3, Wuhan City Pharmaceutical Joint Procurement Office on the release of "Wuhan City 2020 focus on monitoring the rational drug bargaining regulations" and "focus on monitoring reasonable drug bargaining drug catalog" notice, will be 30 large clinical varieties to carry out non-quantitative bargaining procurement.
Wuhan put forward strict requirements for bargaining, effective quotation stakes need to be reduced by at least 30% on the basis of the lowest price at the provincial level of the enterprise, the lowest price of more than two drugs shortlisted, one needs to reach the average decline in order to enter the shortlist.
and the non-finalists will suspend the entire Hubei Province's hanging net, medical institutions are not allowed to purchase.
prices of the province, not shortlisted varieties do not purchase for the bargain drug catalog, Wuhan said that the directory is based on the "National Health And Health Commission Office of the State Administration of Traditional Chinese Medicine Office on the issuance of the first batch of national key monitoring of rational drug catalog (chemical and biological products) notice", Hubei Provincial Health and Health Commission "on the issuance of the first batch of key monitoring of reasonable drug catalogue" in Hubei Province, and Wuhan Medical Institutions to develop a list of key monitoring drugs.
30 varieties include 20 first batch of state-focused monitoring of rational drug drugs in the list of drugs, there are 10 provincial, Wuhan medical institutions focus on monitoring drugs, chemical drugs, Chinese medicine are listed, including ginseng injection, deer melon peptide injection, placental polypeptide injection, propahynodamide glutamine, injection with thrombosis (thrombosis injection) and so on.
in the enterprise declaration, Wuhan requirements must be in Hubei Province platform network and in the past three years with Hubei Province medical institutions have record transactions of the production enterprises, bargaining prices may not be higher than June 30, 2020 the lowest price of the national provincial hanging network (excluding Anhui, Fujian, Guangdong, Chongqing).
specific to the bargaining method, Wuhan proposed that the expert group agreed that the maximum price (effective quotation) of this key monitoring varieties for the enterprise varieties of the lowest price at the provincial level of the country 0.7 times, higher than the maximum price of the price of the price is invalid.
with the same generic name, the same dosage form, the same specifications of the drug qualified declaration enterprises , 2 enterprises for Group A, the lowest effective quotation enterprises to be shortlisted;
it is worth noting that the non-finalist varieties will be suspended in Hubei Province, medical institutions may not carry out procurement, because of clinical needs can apply for a single record procurement.
and centralized procurement of the bargainresults approved by the provincial health insurance bureau, will be implemented in the province-wide joint implementation.
in accordance with the requirements of Wuhan bargaining, it is expected that only a substantial price reduction can be shortlisted, in the lowest price finalists, the non-finalist varieties will lose the entire Hubei Province medical institutions market, I believe that the price competition between enterprises is bound to be very fierce, the exclusive declaration of drugs to achieve the average decline in its price will also bring no small pressure.
in addition, for drug classification, will refer to the "Wuhan City drug centralized band procurement catalog classification measures", the focus of monitoring variety dosage forms and product regulations for the merger of grouping, the same reporting enterprise sgroup can only choose a retail quantity of packaging product regulations to participate in the quotation, after the finalists in principle to supply this packaging regulations, and in accordance with the preparation unit quotation and coefficient multiplied as this product regulation packaging procurement price.
in other words, Wuhan has compressed the rules, enterprises can only participate in a price of a standard, after the election can only supply this rule.
therefore, this requires enterprises in the declaration, to find a way to seize the main product regulations of the market.
the decline of the key monitoring drug market is obviously in accordance with the national management ideas for the key monitoring drugs, the provinces need to form a provincial-level key monitoring of reasonable drug catalog on the basis of the national edition of the catalogue.
all kinds of medical institutions at all levels, on the basis of the provincial catalogue, form the agency's focus on monitoring and rational drug catalog.
for the varieties included in the key monitoring catalogue, medical institutions should establish a key monitoring and rational drug management system, and strengthen the overall management of the clinical application of drugs in the catalogue.
from the catalogues published in various places, very few regions have chosen to directly disable some "assisted drug use" or restrict clinical use.
more areas choose when the use of more, abuse and other circumstances to take appropriate measures.
this time, the local began to focus on monitoring drug prices to make further demands.
in accordance with the Wuhan idea, for the inappropriate volume procurement of key monitoring drugs for centralized bargaining procurement, promote the reasonable formation of prices, guide medical institutions to regulate drug use.
not long ago, Fujian Province issued "on the publication of the first batch of health insurance key monitoring drugs and focus on the list of drugs", the monthly delivery amount of more than 5 million yuan, the production enterprises from the next month in accordance with the relevant provisions to lower the price of the network, and correspondingly adjust the maximum sales price and medical insurance payment standards, lower the hanging price no longer correction.
under the trend of limit and price reduction, the key monitoring varieties market has shrunk.
-meter net statistics show that the country listed a total of 20 key monitoring varieties, a total of 14 belong to more than 1 billion varieties, involving the number of enterprises nearly 100.
2019 in China's public medical institutions terminal, 14 products sales growth rate are negative, single salivary acid tetrahexalysincolic sodium injection, injection with compound coenzyme, injection of sodium phosphonate decline of more than 30%. in addition,
, with the inclusion of Chinese medicine injections in local key monitoring, overlay medical insurance fees, restrictions on outpatient infusions and other policy implications, the size of the Chinese medicine injection market in 2018 has seen a rapid decline.
Sales of Chinese medicine injections at the end of China's public medical institutions fell by 8.54% in 2018, while public hospitals in key cities fell more than the national level, reaching 12.88 percent, according to Minet.com.
look at Wuhan "focus on monitoring reasonable drug price-negotiating drugs catalog" increased 10 varieties, to injection thrombosis, for example, according to the data of the inner net, 2018 injection thrombosis (freeze-dried) sales of more than 5 billion yuan, reached 6.357 billion yuan, ranked in 2018 China's public medical terminal chinese medicine injection products list.
another variety of propaean ethem injections in 2018 key provinces and cities public hospital selling volume of 555 million yuan, from the sales of public hospital terminals in key provinces and cities in recent years, the overall sales of propylene glutamine injections declined, and the decline increased year by year.
in the band purchase everywhere flowering trend, for some large varieties, with the belt as a condition, to promote the variety significantly reduced prices.
for the key monitoring varieties, because the amount of use, the amount of monitoring, perhaps only to reduce prices to preserve the market.
.